0000-0003-3688-3936 About
Dr. Minu Singh is an Associate Professor in the Hematology–Oncology Unit, Department of Pediatrics at the Postgraduate Institute of Medical Dr. Minu Singh is an Associate Professor in the Hematology–Oncology Unit, Department of Pediatrics at the Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India. Trained in molecular biology (PhD, Panjab University), her research focuses on the molecular and genomic underpinnings of pediatric hematological malignancies, particularly acute leukemias.
Her work integrates genomics, transcriptomics, and emerging regulatory mechanisms—including RNA modifications (m6A), non-coding RNAs, pharmacogenomics, and microproteins—to identify novel biomarkers and therapeutic targets. She leads multiple funded projects from national and international agencies, including the American Society of Hematology and the Department of Biotechnology, India.
Dr. Singh has an extensive publication record in high-impact journals and has contributed significantly to understanding treatment response, toxicity, and disease biology in pediatric leukemia. Her research on thiopurine pharmacogenomics, especially involving NUDT15 and TPMT variants, has provided important insights into personalized therapy.
A recipient of several prestigious awards, including the ASH Explorer Pathway Research Award (2024) and UICC fellowships, she is an active member of leading international societies such as ASH, SIOP, EHA, and EACR. Her long-term goal is to translate molecular insights into clinically actionable strategies to improve outcomes and enable precision medicine in pediatric cancer care.
Employment
-
Post Graduate Institute of Medical Education and Research Associate Professor2023 - Present
-
Post Graduate Institute of Medical Education and Research Assistant professor2019 - 2023
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (44)
- Effectiveness and safety of thiopurines in inflammatory bowel disease patients with NUDT15 polymorphism: a real-world retrospective study Save
- Altered Expression of m6A-Associated Genes Is Linked with Poor Prognosis in Pediatric Acute Myeloid Leukemia Patients Save
- Clinical Utility of a Novel Triplex Digital PCR Assay for Clone Monitoring in Sequential and Relapsed Pediatric B-Cell Acute Lymphoblastic Leukemia Patients. Save
- Assessment of cancer predisposition syndromes in children with leukemia and solid tumors: germline-genomic profiling and clinical features in a series of cases Save
- Current insights on m6A RNA modification in acute leukemia: therapeutic targets and future prospects. Save
- Clinical utility of relative telomere length analysis in pediatric bone marrow failure. Save
- Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations. Save
- Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center. Save
- Comprehensive Genomic Analysis Identifies a Diverse Landscape of Sideroblastic and Nonsideroblastic Iron-Related Anemias with Novel and Pathogenic Variants in an Iron-Deficient Endemic Setting. Save
- Novel lncRNAs LINC01221, RP11-472G21.2 and CRNDE are markers of differential expression in pediatric patients with T cell acute lymphoblastic leukemia. Save